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Background: CD147, as a cellular receptor for cyclophilin A 
(CypA), is a multifunctional protein involved in tumor in-
vasion, inflammation, tissue remodeling, neural function, and 
reproduction. Recent observations showing the expression of 
CD147 in leukocytes indicate that this molecule may have 
roles in inflammation. Methods: In order to investigate the 
role of CD147 and its ligand in the pathogenesis of athero-
sclerosis, human atherosclerotic plaques were analyzed for 
the expression pattern of CD147 and CypA. The cellular re-
sponses and signaling molecules activated by the stimulation 
of CD147 were then investigated in the human macrophage 
cell line, THP-1, which expresses high basal level of CD147 
on the cell surface. Results: Staining of both CD147 and 
CypA was detected in endothelial cell layers facing the lu-
men and macrophage-rich areas. Stimulation of CD147 with 
its specific monoclonal antibody induced the expression of 
matrix metalloproteinase (MMP)-9 in THP-1 cells and it was 
suppressed by inhibitors of both ERK and NF-κB. 
Accordingly, the stimulation of CD147 was observed to in-
duce phosphorylation of ERK, phosphorylation-associated 
degradation of IκB, and nuclear translocation of NF-κB p65 
and p50 subunits. Conclusion: These results suggest that 
CD147 mediates the inflammatory activation of macro-
phages that leads to the induction of MMP-9 expression, 
which could play a role in the pathogenesis of inflammatory 
diseases such as atherosclerosis.
[Immune Network 2009;9(3):90-97]
INTRODUCTION
CD147 (EMMPRIN/basigin/HAb18G/neurothelin/M6/TCSF), which 
has two immunoglobulin-like extracellular domains, is a mul-
tifunctional transmembrane glycoprotein with short (39 amino 
acids  long)  intracellular  domain  ( 1 ) .  C D 1 4 7  p l a y s  a  c r i t i c a l  
role in many pathological and physiological processes involv-
ing a variety of cell types such as various cancer cells, leuko-
cytes,  fibroblasts,  and  endothelial  cells  (2-7).  As  a  tu-
mor-derived  MMP  inducer,  CD147  stimulates  fibroblast  and 
endothelial cells to facilitate tumor invasion, metastasis, and 
angiogenesis (7). In addition, CD147 enhances angiogenesis 
through stimulation of the production of vascular endothelial 
growth factor (VEGF) (8). The expression of CD147 has been 
shown to be induced in activated leukocytes such as gran-
ulocytes, lymphocytes, and macrophages (4). Stimulation of 
CD147  in  leukocytes  is  believed  to  be  involved  in  in-
flammatory processes associated with lung injury, rheumatoid 
arthritis (RA), chronic liver disease, heart failure, and athero-
sclerosis  (9-13). 
  The ligands for CD147 were identified to be the two cyclo-
s p o r i n  A  b i n d i n g  p r o t e i n s :  c y c l o p h i l i n  A  a n d  B  ( C y p A  a n d 
CypB) (14,15). A secreted form of CypA, which are expressed 
by smooth muscle cells (SMCs) and macrophages during in-
flammatory conditions (16-18), has been shown to have cyto-
kine-like  functions  (17,19).  The  expression  of  CypA  and 
CD147 was detected in synovial macrophages of RA patients 
and  stimulation  of  CD147  induced  NF-κB-mediated  ex-
pression  of  MMP-9  and  proinflammatory  cytokines  and  en-Role of CD147 in Atherosclerosis
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hanced cell migration in macrophages (20,21). Accordingly, 
blocking the interaction between CD147 and CypA in a colla-
gen-induced arthritis model resulted in a significant reduction 
in  arthritic  symptoms  (22).  Furthermore,  CypA  has  been 
shown to have chemoattractant activity toward CD4
＋ T cells, 
which  up-regulate  the  expression  of  CD147  after  activation 
(23).
    Although CD147 has been shown to be expressed by mac-
rophages in atherosclerotic plaques (11) and in patients with 
acute myocardial infarction (24), the expression pattern and 
role of CD147 in relation to CypA has not been investigated 
simultaneously in the context of atherosclerosis. In this manu-
script, the expression patterns of CD147 and CypA were com-
pared  in  human  atherosclerotic  plaques  and  the  role  of 
CD147, in relation to CypA, was investigated in macrophage 
activation  and  cell  signaling.
MATERIALS AND METHODS
Monoclonal antibodies, cell lines, and reagents
Monoclonal antibodies (mAbs) to CD68 (KP1) and rabbit pol-
yclonal  antibody  to  the  von  Willebrand  factor  (vWF)  were 
purchased  from  DAKO  (Glostrup,  Denmark);  rabbit  poly-
clonal  antibody  to  CypA  was  from  BIOMOL  International 
( P l y m o u t h  M e e t i n g ,  P A ,  U S A ) ;  m A b  f o r  C D 1 4 7  ( c l o n e  
MEM-M6/1) was from Abcam (Cambridge, MA, USA); rabbit 
p o l y c l o n a l  a n t i b o d y  t o  M M P - 9  w a s  f r o m  C h e m i c o n  
(Temecula, CA, USA); mAb for TFIIB (clone 24/TFIIB) was 
from BD-Pharmingen (San Jose, CA, USA); rabbit polyclonal 
antibody  to  IκB,  mAb  to  phospho-IκB  (Ser32/36)  (5A5), 
PD08059,  U0126,  and  polyclonal  antibodies  for  ERK,  phos-
phospho-ERK,  p38,  phospho-p38,  AKT,  and  phospho-AKT 
(Ser473) originated from Cell Signaling (Danvers, MA, USA); 
SB203580,  LY294002,  JNK  inhibitor  I  (JNK-I1),  a  cell-per-
meable fusion protein containing 20 AA of the JNK-binding 
domain of islet-brain and HIV-TAT48-57 (25), and its negative 
control  containing  only  HIV-TAT  were  obtained  from 
Calbiochem International Inc. (La Jolla, CA, USA); TPCK, eth-
yl  pyruvate,  and  sulfasalazine  were  purchased  from  Sigma 
(St. Louis, MO, USA); and mAb for NF-κB p65 subunit (F-6) 
and rabbit polyclonal antibodies for p50 and goat polyclonal 
antibody  for  actin  were  purchased  from  Santa  Cruz  (Santa 
Cruz, CA, USA). Human monocytic leukemia cell line THP-1 
(26) was obtained from the American Type Culture Collection 
(Rockville,  MD,  USA). 
Histological analysis
Carotid endoarterectomy specimens, generously provided by 
Dr.  Jeong-Euy  Park,  Sungkyunkwan  University,  School  of 
Medicine, were obtained from patients, aged between 63 to 
81,  who  had  undergone  surgery  at  the  Samsung  Seoul 
Hospital. The current study was approved by the internal re-
view board. Atherosclerotic plaque specimens were washed 
with  saline  and  embedded  to  produce  frozen  sections.  For 
the  immunohistochemical  analysis,  standard  5-μm  sections 
were stained using an LSAB kit (DAKO, Glostrup, Denmark) 
according to the manual provided by the manufacturer. The 
sections  were  then  counterstained  with  Hematoxylin  which 
stains the nucleus in blue. Finally, the slides were mounted 
in  a  1：1  mixture  of  Xylene  and  Malinol  (Muto  Pure 
Chemicals,  Tokyo,  Japan). 
Cell stimulation, Western blot analysis and gelatin 
zymogram
For the activation utilizing immobilized mAbs, 100μl/well of 
PBS  containing  1  or  10μg/ml  of  antibody  was  incubated 
overnight on a 96-well plate. The wells were washed twice 
with PBS, after which THP-1 cells (1×10
5/well) in 100μl of 
RPMI1640  medium  supplemented  with  0.1%  serum  were 
added. Cell lysates were prepared at appropriate times after 
activation in 100μl of triple-detergent lysis buffer. For the de-
tection of nuclear proteins, cell lysate were prepared in 200 
μl  of  NP-40  lysis  buffer  (0.1%  NP-40,  25  mM  KCl,  5  mM 
MgCl2, 10 mM Tris (pH 8.0), 1 mM PMSF, 1 mM Na3VO4, and 
1 mM NaF). Cell debris containing nucleus was collected and 
nuclear extracts were isolated in 100μl of high salt lysis buf-
f er  ( 0. 1 % N P - 40 ,  50 0  m M  N a Cl,  5  m M  ED TA  (pH  8. 0 ),  1 0 
mM Tris (pH 8.0), 1 mM PMSF, 1 mM Na 3VO4, and 1 mM 
NaF). For the analysis of MMP-9, culture supernatants were 
concentrated 10-fold using a speedvac. Western blot analysis 
was  performed  as  described  previously  (27).  For  the  de-
tection  of  MMP-9  using  gelatin  zymogram,  culture  super-
natants were collected 24 hours after activation. The MMP-9 
activity  in  the  culture  supernatant  was  determined  by  sub-
strate  gel  electrophoresis  as  described  previously  (28). 
RT-PCR
Five micrograms of total RNAs isolated from cells were treat-
ed with RNase free DNase (BD-Pharmingen), and then used 
to generate first-strand cDNAs using a RevertAid
TM first strand 
cDNA synthesis kit with 500 ng oligo (dT)12-18 primers. PCR Role of CD147 in Atherosclerosis
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Figure 1. Endothelial cells and macrophages express CD147 and CypA in atherosclerotic plaques. Human carotid atherosclerotic plaques were 
sequentially sectioned and stained against CD68 (a macrophage marker), vWF (an endothelial cell marker), CD147, CypA. Mouse IgG (mIgG) 
was used for the staining as a negative control. Upper panel shows the plaques area facing the vessel lumen (L). Lower panel shows the shoulder 
area of a plaque which have macrophages and smooth muscle cells (SM). Note the low level staining of CypA in areas rich in SMCs.
primers were designed with ABI PRISM Primer Express 2.0 
(Applied  Biosystems,  Foster  City,  CA,  USA)  and  made  by 
Geno Tech Corp (Daejeon, Korea). Primer sequences are 5’ 
GGCCAGAAAACGGAGTTCAA  3’ ( f o r w a r d )  a n d  5 ’ G C G C -
TTCTCGTAGATGAAGA  3’  (reverse)  for  CD147,  5’ A T C A -
CTGCCACCCAGAAGAC  3’ ( f o r w a r d )  a n d  5 ’  TGAGCTTGA 
CAAAGTGGTCG  3’(reverse)  for  GAPDH.  After  the  PCR  re-
action, the PCR products were run on 2% agarose gel to con-
firm  the  size  and  purity  of  the  PCR  products.
Immunofluorescence assay
The detection of intracellular localization of NF-κB p50 sub-
unit  was  performed  as  described  previously  (20).  Briefly, 
THP-1 cells were stimulated and fixed with 10μl of 4% form-
aldehyde  in  PBS  at  appropriate  time  after  stimulation.  The 
fixed cells were then permeabilized with 1% Triton X-100 in 
P B S  f o r  1 0  m i n u t e s  a t  r o o m  t e m p e r a t u r e  a n d  t h e  p e r -
meabilized cells were then stained with 0.5μg/ml  Hoechst 
staining solution (Sigma, St. Louis, MO, USA) for 30 minutes 
at 37
oC and then washed. The cells were then sequentially 
treated with 10μg/ml anti-p50 polyclonal antibody for 45 mi-
nutes at 37
oC and with a 1：50 dilution of Alexa Fluor 594-la-
beled  goat  anti-rabbit  antibody  (Invitrogen,  Carlsbad,  CA, 
USA)  for  45  minutes  at  37
oC  in  a  humid  chamber.  Finally, 
the cells were dried at room temperature and mounted in a 
1：1  mixture  of  xylene  and  malinol. 
Flow cytometry analysis
For the flow cytometric analysis of cell surface antigens, cells 
(5×10
5)  were  sequentially  incubated  with  0.3μg  of  an-
t i - C D 1 4 7  m A b  a n d  F I T C - l a b e l e d  g o a t  a n t i - m o u s e  I g G  i n  3 0 
μl of FACS solution (a PBS containing 0.5% BSA and 0.1% 
Sodium Azide) for 20 minutes on ice. For background fluo-
rescence,  the  cells  were  stained  with  an  isotype-matching 
control  antibody.  The  fluorescence  profiles  of  2×10
4  cells 
were  collected  and  analyzed  using  FACS-calibur  (Becton- 
Dickinson,  Mountain  View,  CA,  USA).
RESULTS 
In order to analyze the role of CD147 and its ligand (CypA) 
in atherogenic processes, human carotid atherosclerotic pla-
ques were analyzed using immunohistochemical analysis (Fig. 
1). The innermost layer of atherosclerotic plaque facing the 
lumen was lined with endothelial cells which are specifically 
stained with mAb against the von Willebrand factor (vWF). 
vWF is a multimeric glycoprotein essential for thrombus for-
mation and the plasma level of it has been shown to be ele-
vated in patients with atherosclerosis (29,30). Since the ex-
pression of vWF is restricted to platelets and endothelial cells, 
its  presence  has  been used as a endothelial cell  marker in 
a  number  of  studies  employing  immunohistochemistry Role of CD147 in Atherosclerosis
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Figure 2. Human monocyte/macrophage cell lines express high levels
of CD147. (A) THP-1 and U937 cells were stained with anti-CD147
mAb (empty area) or isotype-matching mouse IgG (filled area). (B) 
THP-1 cells were stimulated with or without indicated amounts of 
CypA for 20 hr. Total cellular RNAs were collected and the expression
levels of CD147 or GAPDH mRNA were measured using RT-PCR 
analysis. 
Figure 3. The stimulation of CD147 induced the expression of MMP-9
in THP-1 cells. (A) THP-1 cells were stimulated with anti-CD147 mAb
or isotype-matching mouse IgG (mIgG) that had been immobilized at
indicated concentrations. LPS was used as a positive control. Some
of the cells were also stimulated with antibodies that had been heat 
inactivated at 95
oC for 2 hr. Culture supernatants were collected 24
hr after activation and subjected to gelatin zymogram. (B) THP-1 cells
were stimulated as in (A) and culture supernatants were concentrated
(x10) and subjected to Western blot analysis using MMP-9 specific
antibody. As loading control, the picture of the membrane used for 
Western blot analysis that had been stained with Coomassie Brilliant
Blue is shown at the lower panel. 
(31,32).  Macrophages,  stained  with  anti-CD68  mAb,  were 
found in large numbers at the shoulder region of plaques in 
between thick layers of SMCs (Fig. 1, lower panel). CD147 
expression  was  detected  in  the  innermost  layers  facing  the 
lumen, which corresponds to endothelial cells (Fig. 1, upper 
panel), and in the area corresponding to macrophage-rich re-
gions in the shoulder region (Fig. 1, lower panel). The ex-
pression of CD147 in SMCs was not detected. Interestingly, 
the expression pattern of CypA, the ligand for CD147, was 
similar  to that of  CD147:  both  endothelial cell- and  macro-
phage-rich  areas. 
    Since  macrophages  in  atherosclerotic  plaques  express 
CD147,  monocyte/macrophage  cell  lines  were  used  to  test 
whether  they  express  CD147.  As  shown  in  Fig.  2A,  both 
T H P - 1  a n d  U 9 3 7  c e l l s  e x p r e s s e d  h i g h  l e v e l s  o f  C D 1 4 7 .  
Stimulation of THP-1 cells with CypA did not affect the ex-
pression  levels  of  CD147,  probably  because  the  basal  ex-
pression level of CD147 was already high (data not shown). 
The expression of CD147 in THP-1 was also confirmed using 
RT-PCR (Fig. 2B). THP-1 cells were then used to study the 
signaling pathway initiated from CD147. Since stimulation of 
THP-1 cells with CypA induced the expression of MMP-9 (20), 
CD147  on  the  surface  of  THP-1  cells  were  stimulated  with 
anti-CD147  mAb  and  the  cellular  responses  were  analyzed. 
Anti-CD147 mAb was used instead of CypA, to exclude the 
possibility that CypA may stimulate other yet unknown cel-
lular receptors. Stimulation of the cells with immobilized an-
ti-CD147 mAb induced the secretion of MMP-9 (Fig. 3A). The 
expression levels of MMP-2, which is known to be unaffected 
by cellular activation status, are shown as the internal control. 
Isotype-matching mouse IgG failed to induce the expression 
of  MMP-9  indicating  that  the  induction  of  MMP-9  requires 
specific  interaction  between  CD147  and  the  antibody. 
Furthermore, heat inactivation of anti-CD147 mAb abolished 
the effect indicating that the activation was not induced by 
endotoxins  that  are  heat  resistant.  The  induction  of  MMP-9 
expression  was  also  confirmed  in  the  protein  level  using 
Western  blot  analysis  (Fig.  3B). 
  The expression of MMP-9 in macrophage requires the acti-
vation of NF-κB in macrophages. NF-κB, a heterodimer of 
p65 and p50, stays in cytoplasm in its inactive status in associ-
ation with IκB. When the activation signal(s) is transmitted, 
IκB become phosphorylated and, as a result, degraded by 
proteasome. The free NF-κB heterodimer then translocates 
into the nucleus. In order to analyze the requirement of NF-
κB  activation  in  the  CD147-induced  expression  of  MMP-9, Role of CD147 in Atherosclerosis
Ju-Young Kim, et al.
94 IMMUNE NETWORK http://www.ksimm.or.kr Volume 9 Number 3 June 2009
Figure 4. The stimulation of CD147 induces nuclear translocation of 
NF-κB p65 and p50 subunits. (A) THP-1 cells were stimulated with
1μg/ml of LPS or anti-CD147 mAb that had been immobilized at a
concentration of 10μg/ml. Nuclear extracts were collected after 
indicated times and the Western blot analysis was performed using
p65- or TFIIB-specific antibodies. TFIIB was used as a loading control 
for nuclear extracts. (B, C) THP-1 cells were stimulated with LPS, 
anti-CD147 mAb, or isotype-matching mouse IgG (mIgG) for 2 hr and
analyzed with immunofluorescence analysis using an antibody 
specific for NF-κB p50 subunit. (B) shows representative pictures of 
cells in each samples and (C) shows the percentage of cells that had
NF-κB p50 subunit at their nucleus. 
Figure 5. CD147-induced expression of MMP-9 requires activation of
NF-κB. (A) THP-1 cells were stimulated with 1μg/ml of LPS or 
immobilized anti-CD147 mAb (10μg/ml). Cell lysates were collected
at indicated times and subjected to Western blot analysis using 
antibodies specific for phospho-Iκ B, IκB, and actin. (B) THP-1 cells
were stimulated with indicated amounts of LPS or immobilized 
anti-CD147 mAb in the presence of indicated amounts of NF-κB 
inhibitors (sulfasalazine, TPCK, or ethyl pyruvate). Culture supern-
atants were collected 24 hr after activation and subjected to gelatin 
zymogram.
immunohistochemistry  and  Western  blot  analysis  was  per-
formed using p65 or p50 specific antibodies. As shown in Fig. 
4A, the level of nuclear p65 was increased 30 to 60 min after 
activation with anti-CD147 mAb. In accordance with this data, 
nuclear translocation of NF-κ B p50 subunit was also detected 
in cells stimulated with anti-CD147 mAb (Fig. 4B and 4C). 
  The activation of NF-κB requires the phosphorylation and 
degradation  IκB  in  advance.  When  IκB  levels  were 
a n a l y z e d  a f t e r  t h e  s t i m u l a t i o n  o f  C D 1 4 7  ( F i g .  5 A ) ,  
phosphorylation of Iκ B was observed as early as 15 min after 
stimulation, which continued up to two hours. Accordingly, 
degradation of Iκ B was observed 30 and 60 min after stimu-
lation.  IκB  level  started  to  increase  two  hours  after 
stimulation due to accumulation of newly synthesized IκB. 
Cells stimulated with LPS was used as a positive control. The 
requirement  of  NF-κB  in  CD147-induced  MMP-9  secretion 
was also confirmed using NF-κB-specific inhibitors such as 
ethyl  pyruvate,  sulpasalazine,  and  N-tosyl-L-phenylalanine 
chloromethyl ketone (TPCK). These inhibitors blocked CD147-
induced  expression  of  MMP-9  in  a  dose-dependent  manner 
( F i g .  5 B ) .  T h e s e  d a t a  a r e  i n  a g r e e m e n t  w i t h  p r e v i o u s  d a t a 
showing  the  requirement  of  NF-κB  a c t i v a t i o n  f o r  t h e  e x -
p r e s s i o n  o f  M M P - 9  i n  C y p A - t r e a t e d  T H P - 1  c e l l s  ( 2 0 ) .
  CypA has been reported to induce the activation of ERK1/2 
in various cell types such as cancer cells, neurons, and leuko-
cytes (21,33-35). In order to verify the involvement of MAPKs 
for the expression of MMP-9 in cells stimulated with CD147, 
the assay was performed in the presence of MAPK inhibitors. 
Inhibitors of ERK MAPK (U0126 and PD98059) blocked the 
secretion  of  MMP-9  in  a  dose-dependent  manner  (Fig.  6A, 
note the numbers below each lane). The involvement of ERK 
in CD147-mediated signaling was further confirmed by detect-
ing the phosphorylation of ERK using Western blot analysis 
in cells stimulated with anti-CD147 mAb (Fig. 6B). Interestin-
gly, treatment with inhibitors of p38 and JNK MAPK slightly 
induced MMP-9 expression (Fig. 6A, note the members below 
each lane which represent the relative band intensity). The 
involvement of MAPKs was further confirmed in THP-1 cells 
stimulated with CypA. As shown in Fig. 6C, ERK inhibitors 
suppressed MMP-9 expression in a dose dependent manner, Role of CD147 in Atherosclerosis
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Figure 6. The activation of ERK is involved in the CD147-induced 
expression of MMP-9 and suppression of p38 and JNK activity 
augments the MMP-9 expression. (A) THP-1 cells were stimulated with
1μg/ml LPS or immobilized anti-CD147 mAb (10μg/ml) in the 
presence or absence or indicated amounts of PD98059 (PD), U0126 
(U), SB203580 (SB), JNK inhibitor (JNK-I), or 0.2% DMSO as a vehicle
control (VC). Culture supernatants were collected 24 hr after 
activation and subjected to gelatin zymogram. Numbers below each 
lane represent the band intensity which was normalized with band 
intensity of sample treated with only anti-CD147 in each gel. (B) 
THP-1 cells were stimulated with immobilized anti-CD147 mAb (10 
μg/ml). Cell lysates were collected at indicated times and the levels 
of phospho-ERK or ERK were analyzed using Western blot analysis. 
(C) THP-1 cells were stimulated with 0.1μM of CypA in the presence
or absence of indicated amounts of PD98059 (PD), U0126 (U), 
SB203580 (SB), JNK inhibitor (JNK-I), negative control for JNK-I [J(-)], 
or 0.2% DMSO as a vehicle control (VC). Culture supernatants were
collected 24 hr after activation and subjected to gelatin zymogram.
(D) The bar graph shows the MMP-9 band intensities of each lane 
in panel (C) that was normalized with band intensity of sample treated
with only CypA in each gel.
while the inhibitors of p38 and JNK enhanced the secretion 
of MMP-9 (Fig. 6C and 6D). The enhancement of ERK signal-
i n g  b y  t h e  s u p p r e s s i o n  o f  p 3 8  a n d / o r  J N K  h a s  b e e n  p r e -
viously reported: the presence of p38 inhibitor caused an in-
crease in basal phosphorylation level of ERK, which resulted 
in  the  enhanced  ERK-mediated  signaling  and  cellular  re-
sponses in THP-1 cells (36,37). Similar enhancement of ERK 
phosphorylation  in  the  presence  of  p38  and  JNK  inhibitors 
is likely the cause of the observed phenomenon. The molec-
ular mechanism underlying this suppression of ERK activity 
b y  p 3 8  a n d  J N K  i s  n o t  k n o w n .  
DISCUSSION
The immunohistochemical analysis of human atherosclerotic 
plaques provided the first demonstration showing the co-lo-
calization of CD147 and CypA in atherosclerotic plaques. The 
endothelial expression of CD147 has been previously demon-
strated in cultured cells (38) and in blood brain barrier (39) 
and the result in figure 1 provides the first demonstration of 
endothelial  expression  of  CD1 4 7  i n  a  p a t h o l o g i c a l  t i s s u e  
sample. Although the expression of CD147 was detected in 
cultured SMCs (38), it was not expressed in SMCs of athero-
sclerotic plaques that had been tested in this study. The co-lo-
calization  of  CypA  and  vWF  indicates  that  endothelial  cells 
may  express  CypA.  Endothelial  cells  in  atherosclerotic  pla-
ques  are  in  highly  activated  status  and  express  activation 
markers such as adhesion molecule ICAM-1, proinflammatory 
cytokines, and chemokines (40,41). Since CypA was shown 
to be expressed via activation in inflammatory cells (18), it 
is  likely  that  endothelial  cells  in  atherosclerotic  plaque  ex-
p r e s s e d  h i g h  l e v e l s  o f  C y p A  t h r o u g h  a  s i m i l a r  a c t i v a t i o n  
process. In case of macrophages, a number of studies already 
demonstrated the expression of CD147 in these cells (4,11,24) 
and the activation of them has been shown to induce the se-
cretion  of  CypA  (16).  CypA  is  a  well-known  stimulator  of 
both  macrophages  (20,21)  and  endothelial  cells  (17,38). 
These previous studies, considered together with this current 
data,  suggest  that  CypA  expressed  by  endothelial  cells  and 
macrophages can stimulate itself through CD147 in an auto-
crine manner. Interestingly, low level staining of CypA was 
detected in an area rich in SMCs, although these cells do not 
express CD147 (Fig. 1, lower panel). The expression of CypA 
by SMCs is in agreement with previous observations which 
reported the expression of CypA in SMCs of mouse athero-
sclerotic plaques (17) and in SMCs that had been activated 
with  endotoxins  (18).
    The activation of ERK, after the stimulation of CD147, was 
detected  4  min  after  activation  and  lasted  only  4  more 
minutes. The degradation of IκB and NF-κB nuclear trans-
location  peaks  at  later  time  points.  This  indicates  that  ERK 
activation may be the upstream signaling event that leads to 
the  degradation  of  IκB  and  subsequent  NF-κB  activation. 
Several attempts, however, failed to reveal the linear relation-
ship between ERK and IκB/NF-κB signaling pathway; these 
attempts  included  the  measurement  of  IκB  phosphor-
ylation/degradation  and  NF-κB nuclear translocation in  the Role of CD147 in Atherosclerosis
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presence of ERK inhibitors. This may indicate that the activa-
tion of ERK stimulates MMP-9 expression in a separate path-
w a y  t h a t  d o e s  n o t  i n v o l v e  N F -κB.  Alternatively,  ERK  may 
activate NF-κB activation through other mechanisms such as 
enhancement of p65 phosphorylation, which is known to ac-
company the NK-κB activation and nuclear translocation and 
responsible for the recruitment of coactivators such as p300 
(42,43).
  Our data indicate that CD147 and its ligand, CypA, are ex-
pressed in endothelial cells and macrophages. Furthermore, 
the stimulation of CD147 that are expressed on macrophages 
induces  ERK-  and  NF-κB-mediated  expression  of  MMP-9. 
Macrophages play an essential role in atherogenesis through 
differentiation  into  foamy  macrophages,  secretion  of  proin-
flammatory  cytokines/chemokines  and  growth  factors,  and 
enhancing thrombus formation through the expression of tis-
sue  factors,  etc.  Furthermore,  MMPs  produced  by  macro-
p h a g e s  a r e  r e s p o n s i b l e  f o r  t h e  d e g r a d a t i o n  o f  e x t r a c e l l u l a r  
matrix (ECM). Degradation of ECM proteins results in weak-
ening  of  the  integrity  of  the  plaque  and  leads  to  a  plaque 
rupture and subsequent events leading to blockage of blood 
vessels  (41).  The  inflammatory a c t i v a t i o n  o f  m a c r o p h a g e  i s 
mediated by various mediators of inflammation such as proin-
flammatory  cytokines,  chemokines,  and  cell-cell  interaction 
between  inflammatory  cells.  The  autocrine  interaction  be-
tween  CD147  and  secreted  CypA  is  expected  to  contribute 
to  and  enhance  the  expression  of  MMP-9  in  macrophages, 
which  can  destabilize  atherosclerotic  plaques  by  degrading 
ECM  proteins. 
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